000165374 001__ 165374
000165374 005__ 20240318103532.0
000165374 0247_ $$2doi$$a10.1038/s41591-022-02076-8
000165374 0247_ $$2pmid$$apmid:36253611
000165374 0247_ $$2ISSN$$a1078-8956
000165374 0247_ $$2ISSN$$a1546-170X
000165374 0247_ $$2altmetric$$aaltmetric:137338203
000165374 037__ $$aDZNE-2022-01648
000165374 041__ $$aEnglish
000165374 082__ $$a610
000165374 1001_ $$00000-0002-7786-5825$$aDam, Tien$$b0
000165374 245__ $$aAuthor Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
000165374 260__ $$aNew York, NY$$bNature America Inc.$$c2023
000165374 3367_ $$2DRIVER$$aarticle
000165374 3367_ $$2DataCite$$aOutput Types/Journal article
000165374 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1701772393_15102$$xErratum/Correction
000165374 3367_ $$2BibTeX$$aARTICLE
000165374 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000165374 3367_ $$00$$2EndNote$$aJournal Article
000165374 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000165374 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000165374 7001_ $$aBoxer, Adam L$$b1
000165374 7001_ $$aGolbe, Lawrence I$$b2
000165374 7001_ $$0P:(DE-2719)2811373$$aHöglinger, Günter$$b3$$udzne
000165374 7001_ $$00000-0002-5473-3774$$aMorris, Huw R$$b4
000165374 7001_ $$00000-0002-3485-3445$$aLitvan, Irene$$b5
000165374 7001_ $$aLang, Anthony E$$b6
000165374 7001_ $$aCorvol, Jean-Christophe$$b7
000165374 7001_ $$aAiba, Ikuko$$b8
000165374 7001_ $$aGrundman, Michael$$b9
000165374 7001_ $$aYang, Lili$$b10
000165374 7001_ $$aTidemann-Miller, Beth$$b11
000165374 7001_ $$aKupferman, Joseph$$b12
000165374 7001_ $$aHarper, Kristine$$b13
000165374 7001_ $$00000-0001-6620-0564$$aKamisoglu, Kubra$$b14
000165374 7001_ $$aWald, Michael J$$b15
000165374 7001_ $$aGraham, Danielle L$$b16
000165374 7001_ $$aGedney, Liz$$b17
000165374 7001_ $$aO'Gorman, John$$b18
000165374 7001_ $$aHaeberlein, Samantha Budd$$b19
000165374 7001_ $$aGroup, PASSPORT Study$$b20$$eCollaboration Author
000165374 7001_ $$aAiba, Ikuko$$b21
000165374 7001_ $$aAntonini, Angelo$$b22
000165374 7001_ $$aApetauerova, Diana$$b23
000165374 7001_ $$aAzulay, Jean-Philippe$$b24
000165374 7001_ $$aMartinez, Ernest Balaguer$$b25
000165374 7001_ $$aBang, Jee$$b26
000165374 7001_ $$aBarone, Paolo$$b27
000165374 7001_ $$aBarrett, Matthew$$b28
000165374 7001_ $$aBega, Danny$$b29
000165374 7001_ $$0P:(DE-2719)2000059$$aBerg, Daniela$$b30$$udzne
000165374 7001_ $$aCorrales, Koldo Berganzo$$b31
000165374 7001_ $$aBordelon, Yvette$$b32
000165374 7001_ $$aBoxer, Adam L$$b33
000165374 7001_ $$0P:(DE-2719)2812107$$aBrandt, Moritz$$b34$$udzne
000165374 7001_ $$aBrueggemann, Norbert$$b35
000165374 7001_ $$aCastelnovo, Giovanni$$b36
000165374 7001_ $$aCeravolo, Roberto$$b37
000165374 7001_ $$aChuang, Rosalind$$b38
000165374 7001_ $$aChung, Sun Ju$$b39
000165374 7001_ $$aChurch, Alistair$$b40
000165374 7001_ $$aCorvol, Jean-Christophe$$b41
000165374 7001_ $$aCudia, Paola$$b42
000165374 7001_ $$aDale, Marian$$b43
000165374 7001_ $$aDefebvre, Luc$$b44
000165374 7001_ $$aDrapier, Sophie$$b45
000165374 7001_ $$aDriver-Dunckley, Erika D$$b46
000165374 7001_ $$aEbersbach, Georg$$b47
000165374 7001_ $$aEggert, Karla M$$b48
000165374 7001_ $$aEllenbogen, Aaron$$b49
000165374 7001_ $$aEusebio, Alexandre$$b50
000165374 7001_ $$aEvans, Andrew H$$b51
000165374 7001_ $$aFedorova, Natalia$$b52
000165374 7001_ $$aFinger, Elizabeth$$b53
000165374 7001_ $$aFoubert-Samier, Alexandra$$b54
000165374 7001_ $$aGhosh, Boyd$$b55
000165374 7001_ $$aGolbe, Lawrence$$b56
000165374 7001_ $$aPerez, Francisco Grandas$$b57
000165374 7001_ $$aGrossman, Murray$$b58
000165374 7001_ $$aHall, Deborah$$b59
000165374 7001_ $$aHamada, Kyoko$$b60
000165374 7001_ $$aHasegawa, Kazuko$$b61
000165374 7001_ $$aHoeglinger, Guenter$$b62
000165374 7001_ $$aHonig, Lawrence$$b63
000165374 7001_ $$aHoughton, David$$b64
000165374 7001_ $$aHuang, Xuemei$$b65
000165374 7001_ $$aIsaacson, Stuart$$b66
000165374 7001_ $$aKoh, SeongBeom$$b67
000165374 7001_ $$aBojarski, Jaime Kulisevsky$$b68
000165374 7001_ $$aLang, Anthony E$$b69
000165374 7001_ $$aLeigh, Peter Nigel$$b70
000165374 7001_ $$aLitvan, Irene$$b71
000165374 7001_ $$aLozano, Juan Jose Lopez$$b72
000165374 7001_ $$aMoreno, Jose Luis Lopez-Sendon$$b73
000165374 7001_ $$0P:(DE-2719)2812633$$aLudolph, Albert Christian$$b74$$udzne
000165374 7001_ $$aPiudo, Ma Rosario Luquin$$b75
000165374 7001_ $$aTorres, Irene Martinez$$b76
000165374 7001_ $$aMcFarland, Nikolaus$$b77
000165374 7001_ $$aMeissner, Wassilios$$b78
000165374 7001_ $$aMestre, Tiago$$b79
000165374 7001_ $$aRivera, Pablo Mir$$b80
000165374 7001_ $$aMolho, Eric$$b81
000165374 7001_ $$aMollenhauer, Britt$$b82
000165374 7001_ $$aMorris, Huw R$$b83
000165374 7001_ $$aMurata, Miho$$b84
000165374 7001_ $$aObi, Tomokazu$$b85
000165374 7001_ $$aMagne, Fabienne Ory$$b86
000165374 7001_ $$aO'Suilleabhain, Padraig$$b87
000165374 7001_ $$aPahwa, Rajesh$$b88
000165374 7001_ $$aPantelyat, Alexander$$b89
000165374 7001_ $$aPavese, Nicola$$b90
000165374 7001_ $$aPokhabov, Dmitry$$b91
000165374 7001_ $$0P:(DE-2719)2380559$$aPrudlo, Johannes$$b92$$udzne
000165374 7001_ $$aRodriguez-Porcel, Federico$$b93
000165374 7001_ $$aRowe, James$$b94
000165374 7001_ $$aSavitt, Joseph$$b95
000165374 7001_ $$aSchnitzler, Alfons$$b96
000165374 7001_ $$aSchulz, Joerg B$$b97
000165374 7001_ $$aSeppi, Klaus$$b98
000165374 7001_ $$aShah, Binit$$b99
000165374 7001_ $$aShill, Holly$$b100
000165374 7001_ $$aShprecher, David$$b101
000165374 7001_ $$aStamelou, Maria$$b102
000165374 7001_ $$aSteiger, Malcolm$$b103
000165374 7001_ $$aTakahashi, Yuji$$b104
000165374 7001_ $$aTakigawa, Hiroshi$$b105
000165374 7001_ $$aTartaglia, Carmela$$b106
000165374 7001_ $$aToenges, Lars$$b107
000165374 7001_ $$aTruong, Daniel$$b108
000165374 7001_ $$aTse, Winona$$b109
000165374 7001_ $$aTuite, Paul$$b110
000165374 7001_ $$aVolc, Dieter$$b111
000165374 7001_ $$aWills, Anne-Marie A$$b112
000165374 7001_ $$aWoitalla, Dirk$$b113
000165374 7001_ $$aXie, Tao$$b114
000165374 7001_ $$aYuasa, Tatsuhiko$$b115
000165374 7001_ $$aZauber, Sarah Elizabeth$$b116
000165374 7001_ $$aZesiewicz, Theresa$$b117
000165374 773__ $$0PERI:(DE-600)1484517-9$$a10.1038/s41591-022-02076-8$$n11$$p2955 - 2956$$tNature medicine$$v29$$x1078-8956$$y2023
000165374 7870_ $$0DZNE-2021-01399$$aDam, Tien et.al.$$dNew York, NY : Nature America Inc., 2021$$iRelatedTo$$r$$tSafety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
000165374 8564_ $$uhttps://www.nature.com/articles/s41591-022-02076-8
000165374 8564_ $$uhttps://pub.dzne.de/record/165374/files/DZNE-2022-01648_Restricted.pdf
000165374 8564_ $$uhttps://pub.dzne.de/record/165374/files/DZNE-2022-01648_Restricted.pdf?subformat=pdfa$$xpdfa
000165374 909CO $$ooai:pub.dzne.de:165374$$pVDB
000165374 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811373$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000165374 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2000059$$aExternal Institute$$b30$$kExtern
000165374 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2812107$$aExternal Institute$$b34$$kExtern
000165374 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2812633$$aExternal Institute$$b74$$kExtern
000165374 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2380559$$aExternal Institute$$b92$$kExtern
000165374 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000165374 9141_ $$y2023
000165374 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000165374 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-03
000165374 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000165374 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-08-29$$wger
000165374 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNAT MED : 2022$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-29
000165374 915__ $$0StatID:(DE-HGF)9980$$2StatID$$aIF >= 80$$bNAT MED : 2022$$d2023-08-29
000165374 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x0
000165374 980__ $$ajournal
000165374 980__ $$aVDB
000165374 980__ $$aI:(DE-2719)1111015
000165374 980__ $$aUNRESTRICTED